149 related articles for article (PubMed ID: 33496383)
1. Enhanced anticancer potency of hydroxytyrosol and curcumin by PLGA-PAA nano-encapsulation on PANC-1 pancreatic cancer cell line.
Jadid MFS; Shademan B; Chavoshi R; Seyyedsani N; Aghaei E; Taheri E; Goleij P; Hajazimian S; Karamad V; Behroozi J; Sabet MN; Isazadeh A; Baradaran B
Environ Toxicol; 2021 Jun; 36(6):1043-1051. PubMed ID: 33496383
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the Anti-Cancer Effects of Free and PLGA-PAA Encapsulated Hydroxytyrosol on the MCF-7 Breast Cancer Cell Line.
Safi M; Onsori H; Rahmati M
Curr Mol Med; 2022; 22(7):657-662. PubMed ID: 33390115
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of the Anti-Cancer Effects of Free and PLGA-PAA Encapsulated Hydroxytyrosol on the HT-29 Colorectal Cancer Cell Line.
Sani NS; Onsori H; Akrami S; Rahmati M
Anticancer Agents Med Chem; 2022; 22(2):390-394. PubMed ID: 33687886
[TBL] [Abstract][Full Text] [Related]
4. Folate-PEG/Hyd-curcumin/C18-g-PSI micelles for site specific delivery of curcumin to colon cancer cells via Wnt/β-catenin signaling pathway.
Le TT; Kim D
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():464-471. PubMed ID: 31029341
[TBL] [Abstract][Full Text] [Related]
5. Neuronal Uptake and Neuroprotective Properties of Curcumin-Loaded Nanoparticles on SK-N-SH Cell Line: Role of Poly(lactide-co-glycolide) Polymeric Matrix Composition.
Djiokeng Paka G; Doggui S; Zaghmi A; Safar R; Dao L; Reisch A; Klymchenko A; Roullin VG; Joubert O; Ramassamy C
Mol Pharm; 2016 Feb; 13(2):391-403. PubMed ID: 26618861
[TBL] [Abstract][Full Text] [Related]
6. Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment.
Yallapu MM; Ebeling MC; Khan S; Sundram V; Chauhan N; Gupta BK; Puumala SE; Jaggi M; Chauhan SC
Mol Cancer Ther; 2013 Aug; 12(8):1471-80. PubMed ID: 23704793
[TBL] [Abstract][Full Text] [Related]
7. Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells.
Farajzadeh R; Pilehvar-Soltanahmadi Y; Dadashpour M; Javidfar S; Lotfi-Attari J; Sadeghzadeh H; Shafiei-Irannejad V; Zarghami N
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):917-925. PubMed ID: 28678551
[TBL] [Abstract][Full Text] [Related]
8. Curcumin-Loaded Poly(L-lactide-co-glycolide) Microbubble-Mediated Sono-photodynamic Therapy in Liver Cancer Cells.
Zhu JX; Zhu WT; Hu JH; Yang W; Liu P; Liu QH; Bai YX; Xie R
Ultrasound Med Biol; 2020 Aug; 46(8):2030-2043. PubMed ID: 32475714
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen.
Sutaria D; Grandhi BK; Thakkar A; Wang J; Prabhu S
Int J Oncol; 2012 Dec; 41(6):2260-8. PubMed ID: 23007664
[TBL] [Abstract][Full Text] [Related]
11. Novel multifunctional triple folic acid, biotin and CD44 targeting pH-sensitive nano-actiniaes for breast cancer combinational therapy.
Liu M; Wang B; Guo C; Hou X; Cheng Z; Chen D
Drug Deliv; 2019 Dec; 26(1):1002-1016. PubMed ID: 31571501
[TBL] [Abstract][Full Text] [Related]
12. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
[TBL] [Abstract][Full Text] [Related]
13. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation.
Vakilinezhad MA; Amini A; Dara T; Alipour S
Colloids Surf B Biointerfaces; 2019 Dec; 184():110515. PubMed ID: 31585308
[TBL] [Abstract][Full Text] [Related]
15. Polymeric Nano-Encapsulation of Curcumin Enhances its Anti-Cancer Activity in Breast (MDA-MB231) and Lung (A549) Cancer Cells Through Reduction in Expression of HIF-1α and Nuclear p65 (Rel A).
Khan MN; Haggag YA; Lane ME; McCarron PA; Tambuwala MM
Curr Drug Deliv; 2018 Feb; 15(2):286-295. PubMed ID: 29065834
[TBL] [Abstract][Full Text] [Related]
16. Enhanced anticancer potency of doxorubicin in combination with curcumin in gastric adenocarcinoma.
Firouzi Amoodizaj F; Baghaeifar S; Taheri E; Farhoudi Sefidan Jadid M; Safi M; Seyyed Sani N; Hajazimian S; Isazadeh A; Shanehbandi D
J Biochem Mol Toxicol; 2020 Jun; 34(6):e22486. PubMed ID: 32128952
[TBL] [Abstract][Full Text] [Related]
17. Development of PEGylated PLGA Nanoparticles Co-Loaded with Bioactive Compounds: Potential Anticancer Effect on Breast Cancer Cell Lines.
Mohammadinejad S; Jafari-Gharabaghlou D; Zarghami N
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4063-4072. PubMed ID: 36579986
[TBL] [Abstract][Full Text] [Related]
18. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Nanoencapsulated Curcumin-Fe3O4 on Proliferation and hTERT Gene Expression in Lung Cancer Cells.
Sadeghzadeh H; Pilehvar-Soltanahmadi Y; Akbarzadeh A; Dariushnejad H; Sanjarian F; Zarghami N
Anticancer Agents Med Chem; 2017; 17(10):1363-1373. PubMed ID: 28270067
[TBL] [Abstract][Full Text] [Related]
20. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
